Fny Investment Advisers, LLC Cyto Dyn Inc. Transaction History

Fny Investment Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 14, 2021	SELL	$1.67 - $3.98 $334 - $796	-200 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$2.12 - $7.15 $1,908 - $6,435	-900 Reduced 81.82%	200 $0
Q4 2020 Jan 19, 2021	BUY	$2.02 - $6.0 $202 - $600	100 Added 10.0%	1,100 $5,000
Q3 2020 Oct 09, 2020	BUY	$2.92 - $6.48 $1,168 - $2,592	400 Added 66.67%	1,000 $2,000
Q2 2020 Jul 10, 2020	SELL	$2.25 - $8.77 $1,350 - $5,262	-600 Reduced 50.0%	600 $3,000
Q1 2020 Apr 09, 2020	BUY	$0.85 - $2.67 $1,020 - $3,204	1,200 New	1,200 $3,000

406K

Ticker CYDY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 813,040,000
Market Cap $97.6M
Description
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.